Global Biocompatible Materials Industry
http://www.reportlinker.com/p090557/Global-Biocompatible-Materials-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biomateri
This report analyzes the worldwide markets for Biocompatible Materials in US$ Million by the following Product Segments: Polymeric Materials, Metallic Materials, Natural Materials, and Other Materials. The report provides separate comprehensive analytics for the North America, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 68 companies including many key and niche players such as A.P. Pharma, Inc., Angiotech Pharmaceuticals Inc., Artimplant AB, AST Products, Inc., Biocoat, Inc., DENTSPLY International Inc., Invibio, Integra LifeSciences Holdings Corporation, SaluMedica, LLC, SurModics Inc., Synthes Inc., and United States Surgical. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-3
Quantitative Techniques & Analytics I-3
Product Definition and Scope of Study I-3
Polymeric Materials I-4
Metallic Materials I-4
Natural Materials I-4
Other Materials I-4
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW II-1
Biocompatible Materials Market Continues to Surge, Despite
Recession II-1
Developing Regions to Propel Future Growth II-1
R&D Creates Brighter Avenues II-2
Competitive Scenario II-2
Factors Determining Market Growth II-2
Awareness of Basic Mechanisms of Cell-Material Interaction II-2
Birth of Cross-Disciplinary Field of Tissue Engineering II-2
Rise in Biomaterial Prices II-3
Stem-Cell Technology - A Threat II-3
2. PRODUCT TRENDS II-4
Biomaterials Play Crucial Role in Implants Market II-4
Natural Substances find Increasing Application in Biomaterial
Syntheses II-4
Plastics Being Nudged Out by Newer Substrates II-4
Plastic Companies Join the Fray as Manufacturers of
Biodegradable Materials II-5
Ceramic Fillings as Substitute for Silver-Tin-Mercury Amalgam
Fillings II-5
Ceramics Offer Significant Potential in Crown Syntheses II-5
Hafnium - A Promising Material for Biocompatible Coatings II-5
Chitin as a New Biomaterial II-5
Bioglass - A Potential Material for Bone Regeneration II-6
Collagen - An Efficient Biomaterial for Synthetic Vascular Grafts II-6
Biopolymers as Biomaterials II-6
Bioabsorbable Intelligent Materials II-6
Biocompatible Coatings - A Boon for Medical Implant Applications II-7
Nanotechnology - Revolutionizes Development of Biomaterial
Implants II-7
3. END-USE MARKET ANALYSIS II-8
Biosensors II-8
Implants II-8
Common Orthopedic Implants: Merits and Demerits II-8
Biocompatibility of Implants with Blood II-8
Integrating Heparin to Polymeric Surface II-9
Dental Implants II-9
Recession Decelerates Dental Implant Market, Outlook Remains
Positive II-10
Significant Market Opportunities Exist for Dental Implants II-10
Nanotechnology Permeates Dental Implant Market II-11
Competitive Scenario II-11
Table 1: Global Dental Implant Market by Leading Players
(2009): Market Share Breakdown of Revenue for Nobel
Biocare, Straumann, Biomet/3i, Zimmer Dental, Dentsply and
Others (includes corresponding Graph/Chart) II-11
Joint Implant II-11
Artificial Organs II-12
Artificial Heart II-12
Totally Implantable Artificial Heart (TAH) System II-12
Pneumatic Total Artificial Heart (PTAH) II-12
Cardiopulmonary Bypass System for Long-term Use II-12
Ventricular Assist Device II-12
Artificial Blood Vessels II-12
Artificial Blood II-13
Artificial Skin II-13
Surface Coatings II-13
Materials for Drug Delivery Systems II-13
Polyethylene Glycol as a Drug Delivery System II-14
Hydrogels as Drug Delivery System II-14
Vinylic based Drug Delivery Systems II-14
Collagen Based Drug Delivery System II-14
Electrodes II-14
Tissue Replacement Materials II-15
Dialysis/Separation/Filtration Systems II-15
Dialysis II-15
Filtration and Separation II-16
Cosmetic and Dental Materials II-16
Biomaterials for Cosmetic Formulations II-16
4. RESEARCH AND DEVELOPMENT II-17
Biocompatible Materials - Key Research Objectives II-17
R&D Activity In the Recent Past II-18
French Inventors Develop Three-Dimensional Filet Stitch
Fabric Wall Reinforcement II-18
California Inventor Develops Biocompatible Material II-18
Scientists Develop Process for Producing Biocompatible Fibers II-18
Penn State Researchers Develop New Niobium Molding Process II-18
Doxa Commences Clinical Trials for Novel Biomaterial II-18
FzioMed Concludes Preliminary Study for Oxiplex Gel II-19
MIV's Biomaterial Stent Coating Clears Pyrogen Clinical Testing II-19
5. REGULATORY ENVIRONMENT II-20
FDA Regulations II-20
American Society for Testing and Materials (ASTM) II-20
Joint Research Center (JRC) II-20
Biocompatibility Testing of Materials II-20
Testing Levels II-20
General Biocompatibility Testing II-20
Individual Biocompatibility Testing II-21
Testing Methods II-21
6. PRODUCT OVERVIEW II-22
Biocompatible Materials - An Introduction II-22
Definition of Biocompatible Materials II-22
Applications II-22
Orthopedic Applications II-22
Cardiovascular Applications II-22
Dental Applications II-23
Biomaterials as Skin Replacements II-23
Biomaterials as Scaffolds for Tissue Engineering II-23
Product Segments II-23
Polymeric Materials II-23
Hydrogels II-24
Biodegradable Polymers II-24
Metallic Materials II-25
Natural Materials II-26
Collagen II-26
Hyaluronic Acid II-26
Other Materials II-26
Ceramics II-26
Bioactive Ceramics II-27
Applications II-27
Bone Substitutes II-27
Articulating Surfaces in Joint Implants II-27
Composites II-27
Pyrolitic Carbon II-28
Biomaterial Segments and Applications: An Outline II-28
7. PRODUCT INTRODUCTIONS/INNOVATIONS II-29
Bayer MaterialScience Launches Baymedix Brand II-29
Exotech Bio Solutions Develops Super-Absorbent Polymers II-29
Wacker Launches Silpuran 6600 II-29
Thermo Fisher Scientific Launches HyperSep Retain Polymers II-29
Aesculap to Launch MonoMax Monofilament Absorbable Suture II-30
Lifecore Biomedical Launches Corgel BioHydrogel Research Hydrogel II-30
Incisive Surgical to Unveil Advanced INSORB® Absorbable Staple II-30
AGY Launches HPB Glass Fiber II-30
DSM Biomedical Unveils Modern Application for ComfortCoat II-31
8. PRODUCT INTRODUCTIONS/INNOVATIONS - A HISTORIC PERSPECTIVE BUILDER II-32
Medtronic Launches X-STOP PEEK IPD System II-32
K2M Enters into Biomaterials Sector II-32
Orthovita to Launch Vitoss Bioactive Foam Pack II-32
Cook Medical Unveils Umbilical Hernia Graft II-32
Stratasys Launches ABS-M30i Biocompatible Material II-33
K2M Launches Aleutian AN and Aleutian Anterior II-33
Invibio® Launches ENDOLIGN™ Polymer Composite II-33
Zimmer Dental Launches the Puros® Dermis Allograft Tissue Matrix II-34
Integra Launches Nerve Injury Products II-34
DePuy Mitek Expands Orthopedics Product Portfolio II-35
9. RECENT INDUSTRY ACTIVITY II-36
Stryker Acquires Orthovita II-36
Piramal Healthcare to Acquire Assets of BioSyntech II-36
DSM Biomedical and CID Enter into Partnership II-36
Angiotech Acquires Haemacure's Technology Assets and Product
Candidates II-37
Sigma-Aldrich and Boehringer Ingelheim Pharma Ink Distribution
Agreement II-37
ETEX Corporation's CarriGen Receives FDA Approval II-37
FDA Approves Custom Spine's PATHWAY ACIF II-38
Bayer Material Science Acquires PolyBioMed II-38
Be the first to review this article
